Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schnittger

Showing results (61-70 of 131) with videos related to

Pageof 14
Sort By:
Leukemia|February 20, 2003
Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylateC Schoch, T Haferlach, W Kern, et al.
European Journal of Immunology|March 1, 1994
The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigenU Latza, H Dürkop, S Schnittger, et al.
Leukemia|January 15, 2011
An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profilingJ Flach, F Dicker, S Schnittger, et al.
Leukemia|January 15, 2011
Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasmsS Schnittger, U Bacher, C Haferlach, et al.
Leukemia|February 19, 2010
AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletionsC Haferlach, F Dicker, A Kohlmann, et al.
Leukemia|June 4, 2010
Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AMLF Dicker, C Haferlach, J Sundermann, et al.
Leukemia|February 22, 2013
A novel recurrent AML1-ETO fusion: tight in vivo association with BCR-ABL1L Solari, T Bauer, F Dicker, et al.
Experimental and Clinical Immunogenetics|January 1, 1997
Characterization, mapping and partial cDNA sequence of the 57-kD intracellular Ki-1 antigenJ Kobarg, S Schnittger, C Fonatsch, et al.
Leukemia|December 26, 2001
A comprehensive leukemia database: integration of cytogenetics, molecular genetics and microarray data with clinical information, cytomorphology and immunophenotypingM Dugas, C Schoch, S Schnittger, et al.
Bone Marrow Transplantation|October 19, 2004
Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the diseaseM Weisser, M Schleuning, G Ledderose, et al.
Pageof 14

Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Leukemia|February 20, 2003
Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylateC Schoch, T Haferlach, W Kern, et al.
European Journal of Immunology|March 1, 1994
The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigenU Latza, H Dürkop, S Schnittger, et al.
Leukemia|January 15, 2011
An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profilingJ Flach, F Dicker, S Schnittger, et al.
Leukemia|January 15, 2011
Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasmsS Schnittger, U Bacher, C Haferlach, et al.
Leukemia|February 19, 2010
AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletionsC Haferlach, F Dicker, A Kohlmann, et al.
Leukemia|June 4, 2010
Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AMLF Dicker, C Haferlach, J Sundermann, et al.
Leukemia|February 22, 2013
A novel recurrent AML1-ETO fusion: tight in vivo association with BCR-ABL1L Solari, T Bauer, F Dicker, et al.
Experimental and Clinical Immunogenetics|January 1, 1997
Characterization, mapping and partial cDNA sequence of the 57-kD intracellular Ki-1 antigenJ Kobarg, S Schnittger, C Fonatsch, et al.
Leukemia|December 26, 2001
A comprehensive leukemia database: integration of cytogenetics, molecular genetics and microarray data with clinical information, cytomorphology and immunophenotypingM Dugas, C Schoch, S Schnittger, et al.
Bone Marrow Transplantation|October 19, 2004
Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the diseaseM Weisser, M Schleuning, G Ledderose, et al.
Pageof 14